landed house dun use steel much, compare condo.

Already tell u next hidden gem is scib lo. Still wan ask, already take off. Too late for you guys

Scib

TMR will rebound.

In short term wise, market sentimental toward glove will be very bad. If you do not have anymore fund, suggest to take profit or cut lose. In long term wise, when vaccine news slow down, glove might come back. But not ATH again, unless vaccine giving more side effect. Mercator in Poland oredi drop 17% due to vaccine news. Airline all up.

Logic thinking pls, government tax company, the cost will transfer to end user. They will sell higher price. Then ppl compliant why higher price, want earn pandemic money. No ethic. Then company say u ask my government. He tax me, i transfer u only. Dun want buy, still got ppl buy from me. Logic guys. Impose GST barang ada turun ke?

Next week will side way, still many uncertainty like us election and budget. Next next week, should be fly. Buy red sell green

Read the financial report again. Ansell JV with the company revenue its not calculate in Q3 account onwards. Only share profit. Google what is operating profit and PAT.

Glove Analysis

Cash
1. Supermax RM2.3 Bil
2. Harta RM1.6 Bil
3. Top Glove RM1.2 Bil
4. Kossan RM0.3 Bil (Based on Jun QR)
5. Careplus RM12.2 million
6. Comfort RM62.9 million (based on July QR)
7. Ruberex RM 76 million (Based on Jun QR)


Market Cap
1. TopGlove RM73 Bil
2. Harta RM62.7 Bil
3. Supermax RM26.6 Bil
4. Kossan RM19.2 Bil
5. Careplus RM1.97 Bil
6. Comfort RM2.42 Bil
7. Ruberex RM 1.85 Bil


Latest PAT
1. TopGlove RM1.4 Bil
2. Supermax RM0.79 Bil
3. Harta RM0.55 Bil
4. Kossan RM0.13 Bil (Based on Jun QR)
5. Careplus RM42.8 million
6. Comfort RM42.7 million (based on July QR)
7. Ruberex RM 22.9 million (Based on Jun QR)


Current Price
1. Harta RM18.28
2. Supermax RM9.78
3. Topglove RM8.91
4. Kossan RM7.52
5. Careplus RM3.68
6. Comfort RM4.24
7. Ruberex RM 2.30


PE
1. Harta 60.4
2. Supermax 20
3. Topglove 38
4. Kossan 62.3 (Based on Jun QR)
5. Careplus 24
6. Comfort 31.5 (based on July QR)
7. Ruberex 47.3 (Based on Jun QR)


EPS
1. Harta 29 sen
2. Supermax 47 sen
3. Topglove 22.79 sen
4. Kossan 11.96 sen (Based on Jun QR)
5. Careplus 15 sen
6. Comfort 13 sen (based on July QR)
7. Ruberex 4.7 sen (Based on Jun QR)


Current and Future Capacity
1. Topglove 85.5 Bil, aim to achieve in 2021, 105 Bil (+22.22%)
2. Harta 39 Bil, aim to achieve in 2023, 76 Bil (+94%)
3. Kossan 32 Bil, aim to achieve in 2022, 42.4 Bil (+32%)
4. Supermax 24 Bil, aim to achieve in 2022, 48.4 Bil (+101%)
5. Careplus 4.1 Bil, aim to achieve in 2021, 10.5 Bil (+156%)
6. Comfort 5.4 Bil, aim to achieve in 2021, 5.9 Bil (+9%)
7. Ruberex 1 Bil, aim to achieve in 2022, 3 Bil (+200%)


Profit Margin
1. Supermax 58.4%
2. Topglove 41.6%
3. Harta 40.5%
4. Kossan 18.7% (Based on Jun QR)
5. Careplus 34.9%
6. Comfort 21.6% (based on July QR)
7. Ruberex 26% (Based on Jun QR)

Foker, why revenue do not increase because JV ansell that company revenue do not include in Careplus account. Please read the financial report again.

I look at Careplus from another angle, selling 50% to the world’s three famous PPE brands Ansell. Although this profit will decrease in the short term, it will still be profitable in the long run:

1. Ansell's brand level is one of the best in the world. After careplus JV ansell, the product and development level will definitely be improved

2. Ansell and the Malaysian glove eldest brothers including Harta also have OEMs. After JV, Careplus has the ability to reach Ansell's level of gloves. Generally, orders will be given priority to the subsidiary of this JV. OEM factory, as long as the agreement between the two is negotiated, the fertilizer and water will not enter the field of outsiders

3. In addition to JV's subsidiaries, careplus has improved in all aspects and has better know-how, he can continue to expand his business with other subsidiaries and other brands, and the profit in this area is just around the corner

4. With Ansell JV when introducing their products or brands to customers, they also have a great advantage, and customers' confidence in careplus will also increase a lot.

Overseas, if a store sells ansell, harta, TG and other brands at the same time, even if the price is 10% more expensive, I will still choose ansell, which is also the choice of many foreigners

careplus sell 50% share to Ansell that only one of the subsidiary company. Not all company. which based on Q3 result, that subsidiary company earn 10 million on it, divide by half which give 5 million to CP group. is only 12% on 42 million. another 5 million Ansell take.

But without ansell help sell, i do no think can achieve 10 million profit. Is win win situation.Go google how famous ansell in europe country.

should b

Qr after 5pm just announce

Semua salah. More than u guys expect the PAT. At least x 3 previous qr

This year cp at least got 100 mil PAT. Their business model just like supermx, obm, Oem. They got capacity to sell spot price. So their asp will be higher.

foreign buying. Will know soon. Effect onot, not sure.

look at Friday trading participation data. Foreigner fund is coming back, meanwhile local institutional selling. N local retail is buying lesser. Interpret yourself.

Election news coming out, scare weekend announce, so take cash first. If dun hv, Monday will buy back. There is additional 15 production line fr the new acquired factory it will from 8.8 billion increase till 12 billion end of next years. Do your pe calculation. Is worth at least rm6

below 5 is a steal.

yes. the big 4 fund flow to cheaper glove counter. Eg 1k units of top glove RM26 vs 7k units of careplus RM3.65. So fund will shift some money into cheaper glove counter. And QR report season coming. But bear in mind, its really too hot, dun all in now. buy some and take profit. Wait for retreat enter more.

each glove counter QR out will give good sentimental to market. So all glove counter will follow also.